» Articles » PMID: 9585384

Chronic Hypervitaminosis D3 Determines a Decrease in C-cell Numbers and Calcitonin Levels in Rats

Overview
Publisher Springer
Specialty Endocrinology
Date 1998 May 19
PMID 9585384
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Many papers have reported that chronic hypercalcemia induced either by large doses of vitamin D or by the administration of calcium or parathormone, produces hypertrophy and hyperplasia of C cells. However, more recent studies suggest that the effect of elevated calcium or 1.25(OH)2D3 concentration on the production of calcitonin may be more complex than previously suspected. To assess the validity of such a response an experimental model, where hypercalcemia was induced with vitamin D3 overdose, was designed. Male Wistar rats were administered vitamin D3 chronically (50,000 IU per 100 ml of drinking water with or without CaCl2). Serum calcium and calcitonin levels were determined. C cells were stained by immunohistochemistry using calcitonin and neuronal specific enolase (NSE) antibodies and their percentage was calculated by a morphometric analysis. We also investigated the ultrastructural characteristic of the C cells under experimental conditions. C cells did not have a proliferative response rather a decrease in their number was observed after 1 month of treatment with 25,000 IU of vitamin D3 (1.55 vs 2.43% in control animals) and 3 months with vitamin plus CaCl2 (2.27% vs 3.62% in control animals). In addition, no significant changes in serum calcitonin levels were observed during the experimental period. We conclude that rat C cells do not respond with hypertrophic and hyperplastic changes in a hypercalcemic state due to an intoxication with vitamin D3.

Citing Articles

Effect of modulating dietary vitamin D on the general bone health of rats during posterolateral spinal fusion.

Bhamb N, Kanim L, Maldonado R, Svet M, Metzger M J Orthop Res. 2017; 36(5):1435-1443.

PMID: 29266465 PMC: 5990438. DOI: 10.1002/jor.23832.


The vitamin d receptor in thyroid development and function.

Clinckspoor I, Gerard A, Van Sande J, Many M, Verlinden L, Bouillon R Eur Thyroid J. 2014; 1(3):168-75.

PMID: 24783016 PMC: 3821476. DOI: 10.1159/000342363.

References
1.
Cote G, Rogers D, Huang E, Gagel R . The effect of 1,25-dihydroxyvitamin D3 treatment on calcitonin and calcitonin gene-related peptide mRNA levels in cultured human thyroid C-cells. Biochem Biophys Res Commun. 1987; 149(1):239-43. DOI: 10.1016/0006-291x(87)91630-5. View

2.
Okada H, Toyota N, Harimaya Y, Matsukawa K . Immunohistochemical alterations of C cells in sheep treated with vitamin D. J Comp Pathol. 1991; 105(3):263-70. DOI: 10.1016/s0021-9975(08)80194-6. View

3.
Naveh-Many T, Silver J . Regulation of calcitonin gene transcription by vitamin D metabolites in vivo in the rat. J Clin Invest. 1988; 81(1):270-3. PMC: 442503. DOI: 10.1172/JCI113305. View

4.
Okada H, Saito E, Matsukawa K . Ultrastructure of thyroid C cells in sheep treated with vitamin D3. J Vet Med Sci. 1991; 53(5):921-7. DOI: 10.1292/jvms.53.921. View

5.
Adachi I, Abe K, Tanaka M, Yamaguchi K, Miyakawa S . Plasma human calcitonin (hCT) levels in normal and pathologic conditions, and their responses to short calcium or tetragastrin infusion. Endocrinol Jpn. 1976; 23(6):517-26. DOI: 10.1507/endocrj1954.23.517. View